洛阳建龙微纳新材料股份有限公司 第三届监事会第二十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 洛阳建龙微纳新材料股份有限公司（以下简称"公司"） 第三届监事会第 二十次会议于 2023 年 8 月 21 日（星期一）在河南省洛阳市偃师区产业集聚区工 业区军民路 7 号公司会议室以现场结合通讯的方式召开，会议通知已于 2023 年 8 月 11 日通过通讯方式送达各位监事。本次会议应出席监事 3 人，实际出席监 事 3 人。 会议由监事会主席高培璐主持。会议召开符合有关法律、法规、规章和《公 司章程》的规定。出席会议的监事对各项议案进行了认真审议并做出了如下决议： | 证券代码：688357 | 证券简称：建龙微纳 | 公告编号：2023-067 | | --- | --- | --- | | 转债代码：118032 | 转债简称：建龙转债 | | 洛阳建龙微纳新材料股份有限公司监事会 2023 年 8 月 22 日 表决结果：3 票同意，0 票反对，0 票弃权。 具体内容详见公 ...

洛阳建龙微纳新材料股份有限公司 关于可转债投资者适当性要求的风险提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | 证券代码：688357 | 证券简称：建龙微纳 | 公告编号：2023-066 | | --- | --- | --- | | 转债代码：118032 | 转债简称：建龙转债 | | 投资者如需了解建龙转债的详细情况，请查阅公司 2023 年 3 月 6 日在上海 证券交易所网站（www.sse.com.cn）披露的《洛阳建龙微纳新材料股份有限公司 向不特定对象发行可转换公司债券募集说明书》。 公司现就本次向不特定对象发行可转换公司债券，对不符合科创板股票投资 者适当性要求的公司可转债投资者所持"建龙转债"不能转股的风险，提示性公 告如下： 一、 可转债发行上市概况 经中国证券监督管理委员会证监许可〔2023〕267 号文同意注册，公司于 2023 年 3 月 8 日向不特定对象发行了 7,000,000 张可转换公司债券，每张面值 100 元， 发行总额 70,000 万元。发行方式采用向公司在 ...

投资者可于 2023 年 05 月 24 日(星期三)至 05 月 30 日(星期二)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@jalon.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 洛阳建龙微纳新材料股份有限公司（以下简称"公司"）已于 2023 年 4 月 26 日发布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，公司计划于 2023 年 05 月 31 日下午 13:00-14:30 举 行 2022 年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以视频结合网络互动召开，公司将针对 2022 年度经营成 果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围 内就投资者普遍关注的问题进行回答。 | 证券代码：688357 | 证券简称：建龙微纳 | 公告编号：2023-053 | | --- | --- | --- | | 转债代码：118032 | 转债简称：建龙转债 | | 洛阳建龙微纳新材料股份有限公司 关于召开 2022 年度业绩说明 ...

证券代码：688357 证券简称：建龙微纳 公告编号：2023-049 转债代码：118032 转债简称：建龙转债 洛阳建龙微纳新材料股份有限公司 关于参加河南辖区上市公司 2023 年投资者网上集体 接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为进一步加强与投资者的互动交流，洛阳建龙微纳新材料股份有限公司（以 下简称"公司"）定于 2023 年 5 月 18 日（周四）16:00-17:20 参加在全景网举 办的"真诚沟通 传递价值"河南辖区上市公司 2023 年投资者网上集体接待日 活动。本次活动将采用网络远程的方式举行，投资者可登录"全景·路演天下" （http://rs.p5w.net）参与本次互动交流。 出席本次网上集体接待日活动的人员有：公司副总裁兼董事会秘书李怡丹女 士及相关工作人员（如有特殊情况，参会人员将可能进行调整）。主要就公司 2022 年年报、公司治理、发展战略、经营状况、融资计划、投资者保护、可持续发展 等投资者所关心的问题进行沟通交流。 欢迎广大投资者积极参与。 特此公告。 ...

Financial Performance - The company's operating revenue for 2022 was CNY 853.79 million, a decrease of 2.72% compared to 2021[22]. - Net profit attributable to shareholders decreased by 28.16% to CNY 197.86 million, while net profit after deducting non-recurring gains and losses fell by 37.20% to CNY 154.36 million[22]. - Total assets increased by 29.99% to CNY 2.19 billion, and net assets attributable to shareholders rose by 26.55% to CNY 1.55 billion[22]. - Basic earnings per share were CNY 3.36, down 29.41% year-on-year, while the weighted average return on equity was 13.89%, a decrease of 10.27 percentage points[23][25]. - The company's operating revenue for the reporting period was CNY 853.79 million, a decrease of 2.72% compared to the previous year[94]. - Operating costs increased by 22.09% to CNY 572.85 million, primarily due to rising prices of key raw materials such as lithium salts[94]. Cash Flow and Investments - The net cash flow from operating activities decreased by 108.40%, primarily due to rising procurement costs from lithium salts and other raw materials[24]. - The net cash flow from operating activities showed a negative trend throughout the year, with Q4 reporting a net cash outflow of -¥17,188,292.47[27]. - The net cash flow from investing activities was -CNY 59.13 million, reflecting an increase in the recovery of financial management funds[95]. - The net cash flow from financing activities was CNY 124.11 million, primarily due to the issuance of shares to specific investors[95]. Research and Development - Research and development expenses accounted for 4.45% of operating revenue, a slight decrease from 4.80% in the previous year[24]. - The company’s R&D investment for 2022 was 38.00 million yuan, resulting in 7 new invention patents, bringing the total to 32 authorized patents[37]. - The company is collaborating with various universities and research institutes to enhance its R&D capabilities and product development[67]. - The company has established several research and innovation platforms to support technological advancements, including the "Henan Province Inorganic Adsorption Materials Academician Workstation" and "Henan Province Adsorption Molecular Sieve Engineering Technology Research Center"[128]. Market and Competitive Position - The company is positioned in the chemical raw materials manufacturing industry, facing competition from both international and domestic players[44]. - The company is a leader in the domestic molecular sieve industry, continuously increasing R&D investment and expanding production scale to meet rising market demand[53]. - The global molecular sieve market size was $12.8 billion in 2021 and is projected to reach $15.7 billion by 2026, with a compound annual growth rate (CAGR) of 4.17% from 2021 to 2026[55]. - The company aims to enhance its competitive edge through technological innovation and resource integration, leading to a gradual increase in market concentration[45]. Governance and Compliance - The company has received a standard unqualified audit report from its accounting firm, indicating the financial statements are accurate and complete[5]. - The company confirmed that all board members attended the board meeting, ensuring governance compliance[5]. - The company held one annual general meeting and one extraordinary general meeting during the reporting period, with all proposed resolutions approved by shareholders[163]. - The board of directors held nine meetings during the year, reviewing and approving key matters including the annual report[158]. Risks and Challenges - The company has outlined potential risk factors in its operations, which can be found in the management discussion and analysis section[4]. - The company is exposed to raw material price fluctuations, particularly for lithium salts and sodium hydroxide, which could adversely affect performance if prices rise significantly[87]. - The company faces risks related to product iteration, as competitors may introduce more efficient and environmentally friendly molecular sieves, potentially impacting market share[85]. - The company is at risk of losing core technical personnel, which could impact its innovation capabilities and product development[86]. Strategic Initiatives - The company plans to distribute a cash dividend of 10.00 RMB per 10 shares (including tax) and to increase capital by 4 shares for every 10 shares held, resulting in a total capital increase of 23,779,939 shares[5]. - The company plans to expand its market presence and enhance product development in response to rising raw material costs[24]. - The company aims to enhance the adsorption capacity and selectivity of molecular sieve products through exchange modification, facilitating import substitution[58]. - Future strategies include expanding into hydrogen purification, coal-to-ethanol, and environmental remediation fields, enhancing product structure and ensuring sustainable development[152].

重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人李建波、主管会计工作负责人张景涛及会计机构负责人（会计主管人员）于鲁杰保证 季度报告中财务信息的真实、准确、完整。 2023 年第一季度报告 证券代码：688357 证券简称：建龙微纳 转债代码：118032 转债简称：建龙转债 洛阳建龙微纳新材料股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年 | | --- | --- | --- | | | | 同期增减变动幅 | | | | 度(%) | | 营业收入 | 325,977,322.88 | 65.58 | | 归属于上市公司股东的净利润 | 60,546,221.78 | 38.05 | | 归属于上市 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥213,569,980.41, a decrease of 27.88% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥53,608,533.20, down 45.73% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥36,911,339.22, a decline of 60.37% compared to the previous year[5]. - The basic earnings per share for the period was ¥0.91, a decrease of 46.78% year-on-year[6]. - Net profit for the third quarter of 2022 was ¥135,272,625.60, compared to ¥200,619,524.75 in the same quarter of 2021, reflecting a decrease of approximately 32.5%[20]. - The total comprehensive income for the third quarter of 2022 was CNY 131,214,409.68, a decrease from CNY 190,621,471.44 in the same period of 2021, representing a decline of approximately 31.1%[21]. - Basic and diluted earnings per share for Q3 2022 were CNY 2.30, down from CNY 3.47 in Q3 2021, reflecting a decrease of about 33.7%[21]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,006,381,034.84, an increase of 19.31% from the end of the previous year[6]. - The company's total assets as of the end of the third quarter of 2022 amounted to ¥2,006,381,034.84, compared to ¥1,681,652,249.15 at the end of the same quarter in 2021, marking an increase of about 19.3%[19]. - Total liabilities increased to ¥536,445,812.61 in the third quarter of 2022 from ¥457,312,255.53 in the same quarter of 2021, representing a rise of approximately 17.3%[18]. - The company's cash and cash equivalents were not explicitly detailed, but total current assets reached ¥1,047,097,090.35, up from ¥919,230,186.16 in the previous year, indicating a growth of about 13.9%[18]. Cash Flow - The cash flow from operating activities showed a net outflow of ¥15,399,229.33, representing a decrease of 104.57% compared to the previous year[6]. - Cash inflows from operating activities for the first three quarters of 2022 totaled CNY 456,283,729.84, compared to CNY 554,609,430.46 in the same period of 2021, indicating a decline of approximately 17.7%[23]. - The net cash flow from operating activities for the first three quarters of 2022 was negative CNY 15,399,229.33, contrasting with a positive CNY 336,714,681.17 in the previous year[23]. - Cash inflows from investment activities for the first three quarters of 2022 amounted to CNY 3,252,055,198.28, an increase from CNY 2,484,711,308.42 in 2021, representing a growth of about 30.9%[23]. - The net cash flow from investment activities was negative CNY 116,428,289.62 for the first three quarters of 2022, compared to negative CNY 185,925,680.02 in the same period of 2021, showing an improvement[23]. - Cash and cash equivalents at the end of Q3 2022 were CNY 88,245,151.50, down from CNY 207,822,627.82 at the end of Q3 2021, a decrease of approximately 57.6%[24]. - The net cash flow from financing activities for the first three quarters of 2022 was CNY 119,508,311.47, compared to negative CNY 70,730,847.22 in the same period of 2021, indicating a significant turnaround[24]. Shareholder Information - The top shareholder, Li Jianbo, holds 14,350,000 shares, representing 24.23% of the total shares[13]. - The second-largest shareholder, Shenzhen Shenyunlong Investment Development Co., Ltd., owns 5,000,000 shares, accounting for 8.44%[13]. - The company has a total of 5,502 common shareholders as of the report date[13]. - The report indicates that there are no significant changes in the status of major shareholders participating in margin financing and securities lending[15]. Research and Development - Research and development expenses totaled ¥10,735,812.47, accounting for 5.03% of operating revenue, which is an increase of 1.23 percentage points year-on-year[6]. - Research and development expenses for the first three quarters of 2022 were ¥28,740,413.54, slightly higher than ¥28,002,405.20 in the same period of 2021, showing an increase of approximately 2.6%[19]. Other Information - The company received government subsidies that were lower than the same period last year, impacting net profit negatively[11]. - The decline in net profit was primarily due to rising raw material costs outpacing revenue growth[11]. - The company has not disclosed any new strategies or future outlook in the current report[16]. - There are no significant audit opinions applicable to the financial statements for the reporting period[16].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2022, representing a year-on-year increase of 15%[1]. - The company's operating revenue for the first half of 2022 was approximately CNY 404.31 million, representing a 30.23% increase compared to CNY 310.46 million in the same period last year[22]. - The net profit attributable to shareholders decreased by 19.81% to approximately CNY 81.66 million, down from CNY 101.84 million in the previous year[22]. - The basic earnings per share for the first half of 2022 was CNY 1.39, a decrease of 21.02% from CNY 1.76 in the same period last year[22]. - The net cash flow from operating activities dropped significantly by 99.61% to approximately CNY 622,765, primarily due to increased cash payments for goods and services[22]. - The company has set a performance guidance of RMB 2.5 billion in revenue for the full year 2022, reflecting a growth target of 20%[1]. - The company's gross profit margin improved to 35%, up from 30% in the same period last year[1]. - The decline in net profit was primarily due to rising prices of raw materials and energy, leading to significantly higher production costs[22]. Research and Development - Research and development expenses increased by 25%, totaling RMB 150 million, focusing on new technology innovations[1]. - Research and development expenses accounted for 4.45% of operating revenue, a decrease of 0.94 percentage points from the previous year[22]. - The company has established a comprehensive innovation system, increasing R&D investment to achieve breakthroughs in core technologies[29]. - The company collaborates with universities and research institutions to enhance its R&D capabilities and accelerate the commercialization of research outcomes[30]. - The company has completed multiple technology reserves, including denitrification molecular sieves and catalysts, and has obtained several national invention patents[48]. - The number of R&D personnel increased from 61 to 78, with R&D personnel accounting for 10.54% of the total workforce[60]. Market Expansion and Strategy - The company plans to launch two new products in Q3 2022, targeting a market expansion of 10% in the next fiscal year[1]. - The company has outlined a strategic goal to enter the Southeast Asian market by the end of 2022, aiming for a market share of 5%[1]. - The company aims to support the "dual carbon" goals through the development of molecular sieve products that facilitate the transition to high-quality development in the petrochemical industry[38]. - The company is actively diversifying its product applications into energy and chemical fields, including coal-to-ethanol and coal-to-propylene[32]. Environmental Compliance and Sustainability - The company emphasizes environmental protection and has invested in new generation environmental treatment systems to reduce production pollution[66]. - The company has implemented a comprehensive wastewater treatment process, including initial sedimentation and pH adjustment, to manage production wastewater[114]. - The company has established a solid waste management system in compliance with national standards to prevent secondary pollution[114]. - The company has installed pollution control facilities, including cyclone separators and low-nitrogen burners, to treat exhaust gases[114]. - The company has reduced electricity consumption and greenhouse gas emissions by optimizing processes in response to national "carbon neutrality" policies[121]. - The company has not reported any significant changes in its environmental compliance status[112]. Risks and Challenges - Risk factors related to supply chain disruptions were highlighted, with potential impacts on production timelines[1]. - The company faces market competition risks from both international and domestic molecular sieve manufacturers, which could weaken its core competitiveness if it fails to innovate[72]. - The company is exposed to risks from rising raw material prices, which could adversely affect its gross margin and profitability if product sales prices do not increase correspondingly[72]. - The company’s overseas market expansion may be negatively impacted by a potential global economic downturn affecting the capacity release and market development of its subsidiary in Thailand[73]. Shareholder Information - The company raised a total of CNY 625.83 million in its initial public offering, with a net amount of CNY 569.92 million after deducting issuance costs[157]. - The total number of shares increased to 59,228,885 after the issuance of 1,235,039 new shares[168]. - The largest shareholder, Li Jianbo, holds 14,350,000 shares, representing 24.23% of total shares[174]. - The top ten shareholders collectively hold a significant portion of the company's equity, with the top three alone accounting for over 39%[174]. - The company has a diverse shareholder base, including both individual and institutional investors[176]. Financial Position - The company's total assets increased by 19.11% to approximately CNY 2.00 billion, up from CNY 1.68 billion at the end of the previous year[22]. - The company's total liabilities reached CNY 588,538,881.07, up from CNY 457,312,255.53, indicating a growth of around 28.7%[190]. - Owner's equity increased to CNY 1,414,493,507.62 from CNY 1,224,339,993.62, showing a growth of about 15.5%[190]. - Cash and cash equivalents amounted to CNY 174,430,726.32, up from CNY 137,604,402.31, representing a growth of approximately 27%[193].

2022 年第一季度报告 证券代码：688357 证券简称：建龙微纳 洛阳建龙微纳新材料股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同期 增减变动幅度(%) | | --- | --- | --- | | 营业收入 | 196,874,549.15 | 56.95 | | 归属于上市公司股东的净利 | 43,859,750.57 | 33.59 | | 润 | | | | 归属于上市公司股东的扣除 | 40,252,684.89 | 43.59 | | 非 ...

2021 年年度报告 公司代码：688357 公司简称：建龙微纳 洛阳建龙微纳新材料股份有限公司 2021 年年度报告 1 / 263 2021 年年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司上市时未盈利且尚未实现盈利 □是 √否 三、 重大风险提示 公司已在本报告中阐述了公司在生产经营过程中可能面临的风险因素，敬请查阅"第三节管 理层讨论与分析/四、风险因素"部分。 四、 公司全体董事出席董事会会议。 五、 立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 六、 公司负责人李建波、主管会计工作负责人张景涛及会计机构负责人（会计主管人员）于鲁杰 声明：保证年度报告中财务报告的真实、准确、完整。 七、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2022年3月9日经公司第三届董事会第九次会议决议通过2021年度利润分配预案：上市公司拟 向全体股东每10股派发现金红利15.00元（含税）。 截 至 2021 年12 月 31 日 ...